| __timestamp | Regeneron Pharmaceuticals, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1271353000 | 9804000 |
| Thursday, January 1, 2015 | 1620577000 | 12796000 |
| Friday, January 1, 2016 | 2052295000 | 15324000 |
| Sunday, January 1, 2017 | 2075142000 | 13881000 |
| Monday, January 1, 2018 | 2186100000 | 14820000 |
| Tuesday, January 1, 2019 | 3036600000 | 14851000 |
| Wednesday, January 1, 2020 | 2735000000 | 17204000 |
| Friday, January 1, 2021 | 2908100000 | 29843000 |
| Saturday, January 1, 2022 | 3592500000 | 40603000 |
| Sunday, January 1, 2023 | 4439000000 | 57305000 |
| Monday, January 1, 2024 | 5132000000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Regeneron Pharmaceuticals, Inc. has consistently outpaced Veracyte, Inc. in R&D investment. From 2014 to 2023, Regeneron's R&D expenses surged by approximately 250%, reaching a peak in 2023. This robust growth underscores Regeneron's strategic focus on pioneering new treatments and therapies. In contrast, Veracyte's R&D spending, while growing, remains modest, increasing by nearly 500% over the same period. This disparity highlights the different scales and strategies of these two companies. As the biotech landscape continues to shift, understanding these financial commitments offers valuable insights into future innovations and market dynamics.
R&D Insights: How Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Veracyte, Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alnylam Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Axsome Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and ImmunityBio, Inc.
Regeneron Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Regeneron Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Axsome Therapeutics, Inc. and Veracyte, Inc. Allocate Funds
R&D Insights: How TG Therapeutics, Inc. and Veracyte, Inc. Allocate Funds